Publication:
Addition of Thalidomide (T) to Oral Melphalan/Prednisone (MP) in Patients with Multiple Myeloma: Initial Results of a Randomized Trial From the Turkish Myeloma Study Group.

Simple item page
dc.contributor.authorsBeksac, Meral; Haznedar, Rauf; Firatli-Tuglular, Tulin; Ozdogu, Hakan; Aydogdu, Ismet; Konuk, Nahide; Sucak, Gulsan; Kaygusuz, Isik; Karakus, Sema; Kaya, Emin; Ali, Ridvan; Gulbas, Zafer; Ozet, Gulsum; Goker, Hakan; Undar, Levent
dc.date.accessioned2022-03-12T16:01:20Z
dc.date.accessioned2026-01-11T19:24:03Z
dc.date.available2022-03-12T16:01:20Z
dc.date.issued2009
dc.identifier.doidoiWOS:000272725802248
dc.identifier.issn0006-4971
dc.identifier.urihttps://hdl.handle.net/11424/224846
dc.identifier.wosWOS:000272725802248
dc.language.isoeng
dc.publisherAMER SOC HEMATOLOGY
dc.relation.ispartofBLOOD
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleAddition of Thalidomide (T) to Oral Melphalan/Prednisone (MP) in Patients with Multiple Myeloma: Initial Results of a Randomized Trial From the Turkish Myeloma Study Group.
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage747
oaire.citation.issue22
oaire.citation.startPage746
oaire.citation.titleBLOOD
oaire.citation.volume114

Files

Collections

Araştırma Çıktıları